Back to Trades
Mottola Frank
SVPChief Tech. Ops. OfficerCIK 0001804567
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 6
- Buy transactions
- 0
- Sell transactions
- 4
- Companies
- 1
- Active
- 2025–2026
Across 6 filings between 2025–2026, Mottola Frank, SVP, Chief Tech. Ops. Officer, has disclosed $4.5M in transactions — all concentrated in SUPERNUS PHARMACEUTICALS, INC. (SUPN). Their disclosed trades are heavily weighted toward selling — $0 in buys and $1.9M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
6 loaded
| Aug 14 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Chief Tech. Ops. Officer | Exercise | $37.1K |
| Jul 31 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Chief Tech. Ops. Officer | Award | $0 |
| Feb 20 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Chief Tech. Ops. Officer | Award | $677.7K |
| Dec 22 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Chief Tech. Ops. Officer | Sell | $1.0M |
| Sep 15 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Chief Tech. Ops. Officer | Sell | $229.3K |
| Aug 27 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Quality, GMP, Ops, IT | Sell | $623.1K |
6 filings